Satralizumab in Aneurysmal Subarachnoid Hemorrhage
Status:
Not yet recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
In this study, satralizumab will be administered to see whether satralizumab is safe in
patients with a burst brain aneurysm and if it may prevent strokes in patients with a burst
brain aneurysm.